Repare Therapeutics (RPTX)

RPTX was delisted on the 27th of January, 2026.

• Sector: Healthcare
• Industry: Biotechnology

About: Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Employees: 129